Evidence map›Paper›PMID 31372826›Full record

ArticleMedical & biological engineering & computing2019

Biomechanical modeling of transcatheter aortic valve replacement in a stenotic bicuspid aortic valve: deployments and paravalvular leakage.

Karin Lavon, Gil Marom, Matteo Bianchi, Rotem Halevi, Ashraf Hamdan, Adi Morany, Ehud Raanani, Danny Bluestein, Rami Haj-Ali

Open access · greenAbstract read
In one paragraph

Article in Medical & biological engineering & computing, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. [Structural design and mechanical analysis of a "drum-shaped" balloon-expandable valve stent in expanded configuration].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Karin LavonSchool of Mechanical Engineering, Tel Aviv University, Tel Aviv, Israel.
Gil MaromSchool of Mechanical Engineering, Tel Aviv University, Tel Aviv, Israel.
Matteo BianchiDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, NY, USA.
Rotem HaleviSchool of Mechanical Engineering, Tel Aviv University, Tel Aviv, Israel.
Ashraf HamdanDepartment of Cardiology, Rabin Medical Center, Petah Tikva, Israel.
Adi MoranySchool of Mechanical Engineering, Tel Aviv University, Tel Aviv, Israel.
Ehud RaananiDepartment of Cardio- thoracic Surgery, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Danny BluesteinDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, NY, USA.
Rami Haj-AliSchool of Mechanical Engineering, Tel Aviv University, Tel Aviv, Israel. rami98@tau.ac.il.
Tel Aviv University · ILStony Brook University · USRabin Medical Center · ILSheba Medical Center · IL

Funding

Biomechanical Approaches and Technologies for Enhancing TAVR OutcomesU01EB026414 · NIBIB · STATE UNIVERSITY NEW YORK STONY BROOK · PI BLUESTEIN, DANNY · 2018 to 2022
$3.8M
NIBIB NIH HHS BRP U01EB026414NIBIB NIH HHS U01 EB026414
6 · The paper itself

Abstract

Calcific aortic valve disease (CAVD) is characterized by stiffened aortic valve leaflets. Bicuspid aortic valve (BAV) is the most common congenital heart disease. Transcatheter aortic valve replacement (TAVR) is a treatment approach for CAVD where a stent with mounted bioprosthetic valve is deployed on the stenotic valve. Performing TAVR in calcified BAV patients may be associated with post-procedural complications due to the BAV asymmetrical structure. This study aims to develop refined computational models simulating the deployments of Evolut R and PRO TAVR devices in a representative calcified BAV. The paravalvular leakage (PVL) was also calculated by computational fluid dynamics simulations. Computed tomography scan of severely stenotic BAV patient was acquired. The 3D calcium deposits were generated and embedded inside a parametric model of the BAV. Deployments of the Evolut R and PRO inside the calcified BAV were simulated in five bioprosthesis leaflet orientations. The hypothesis of asymmetric and elliptic stent deployment was confirmed. Positioning the bioprosthesis commissures aligned with the native commissures yielded the lowest PVL (15.7 vs. 29.5 mL/beat). The Evolut PRO reduced the PVL in half compared with the Evolut R (15.7 vs. 28.7 mL/beat). The proposed biomechanical computational model could optimize future TAVR treatment in BAV patients. Graphical abstract.

Indexed as

Transcatheter Aortic Valve ReplacementAgedAortic ValveAortic Valve StenosisBicuspid Aortic Valve DiseaseBiomechanical PhenomenaComputer SimulationElasticityFemaleFinite Element AnalysisHeart Valve DiseasesHumansHydrodynamicsModels, CardiovascularPressureStentsBicuspid aortic valveComputational fluid dynamicsFinite elementParavalvular leakageTranscatheter aortic valve replacement

Identifiers

PMID31372826
PMCPMC6801083
OpenAlexW2966382418

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.